Ontasameran

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Substance Class	Nucleic Acid Created by `admin` on `Sat Dec 16 16:19:22 GMT 2023` Edited by `admin` on `Sat Dec 16 16:19:22 GMT 2023`
Nucleic Acid Type	mRNA VACCINE
Nucleic Acid Subtype	TRANSGENE
Sequence Type	COMPLETE
Record UNII	WVT3HJM1DN
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

Ontasameran

Official Name

English

MESSENGER RNA ENCODING TRANSMEMBRANE PHOSPHATASE WITH TENSIN HOMOLOGY (TPTE). MESSENGER RNA (MRNA), 5'-CAPPED, ENCODING CODON-OPTIMISED TRANSMEMBRANE PHOSPHATASE WITH TENSIN HOMOLOGY (TPTE; CANCER/TESTIS ANTIGEN 44) EXPRESSED AS A FUSION PROTEIN COMPRISI

Common Name

English

RBL-004.3

Code

English

BNT-111 COMPONENT ONTASAMERAN

Common Name

English

ontasameran [INN]

Common Name

English

RBL004.3

Code

English

RNA (recombinant [1,2-[m7Gm-p-[P(R)]-sp-p-G]]-capped human transmembrane phosphatase with tensin homology (TPTE)-specifying poly(A)-tailed messenger RBL004.3), inner salt

Common Name

English

ONTASAMERAN [USAN]

Common Name

English

Code System Code Type Description

NCI_THESAURUS

C175832

Created by admin on Sat Dec 16 16:19:22 GMT 2023 , Edited by admin on Sat Dec 16 16:19:22 GMT 2023

PRIMARY

INN

11480

Created by admin on Sat Dec 16 16:19:22 GMT 2023 , Edited by admin on Sat Dec 16 16:19:22 GMT 2023

PRIMARY

USAN

KL-143

Created by admin on Sat Dec 16 16:19:22 GMT 2023 , Edited by admin on Sat Dec 16 16:19:22 GMT 2023

PRIMARY

CAS

2348561-00-0

Created by admin on Sat Dec 16 16:19:22 GMT 2023 , Edited by admin on Sat Dec 16 16:19:22 GMT 2023

PRIMARY

FDA UNII

WVT3HJM1DN

Created by admin on Sat Dec 16 16:19:22 GMT 2023 , Edited by admin on Sat Dec 16 16:19:22 GMT 2023

PRIMARY

Sugar	Site Range	Site Count
D-Ribose (RNA)	1_1-1_2675	2675 / 2675

Linkage	Site Range	Site Count
Phosphate	1_2-1_2675	2674 / 2674

Related Record Type Details


					MA53Z5C2K6

HUMAN MELANOMA CELL

TARGET->VACCINE ANTIGEN

Amount:

Related Record Type Details


					WVT3HJM1DN

ACTIVE MOIETY

Comments:

Immunomodulator, antineoplastic

Amount:

Structural Modifications

Modification Type	Location Site	Location Type	Residue Modified	Extent	Fragment Name	Fragment Approval
NUCLEOTIDE SUBSTITUTION	[1_1]	5'-TERMINUS			UNSPECIFIED SUBSTANCE	fd4a4c35 (not in database)